Charles River Laboratories Announces Fourth-Quarter and Full-Year 2017 Results from Continuing Operations and Provides 2018 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. META
4. ABBV
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Charles River Laboratories Announces Fourth-Quarter and Full-Year 2017 Results from Continuing Operations and Provides 2018 Guidance

Charles River Labs (CRL) PT Lowered to $115 at Evercore ISI

February 13, 2018 12:28 PM EST

Evercore ISI lowered its price target on Charles River Labs (NYSE: CRL) to $115.00 (from $117.00) while maintaining a In Line rating.

The firm lowered FY18 EPS from $5.80 to $5.75, FY19 from $6.55 to $6.45 and FY20 from $7.50 to $7.15.

... More

Charles River Laboratories (CRL) Tops Q4 EPS by 15c

February 13, 2018 7:04 AM EST

Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $1.40, $0.15 better than the analyst estimate of $1.25. Revenue for the quarter came in at $478.5 million versus the consensus estimate of $474.59 million.

GUIDANCE:

Charles River Laboratories sees FY2018 EPS of $5.42-$5.57, versus the consensus... More